시장보고서
상품코드
1151947

세계의 성감염증(STD) 검사 시장 규모 조사와 예측 : 질환 유형별, 검사장소별, 지역별 분석(2022-2029년)

Global Sexually Transmitted Diseases Testing Market Size study & Forecast, by Disease Type and Location of Testing and Regional Analysis, 2022-2029

발행일: | 리서치사: Bizwit Research & Consulting LLP | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 성감염증(STD) 검사 시장은 2021년에 약 960억 6000만 달러로 평가되며, 예측 기간인 2022-2029년에는 5.1% 이상의 건전한 성장률로 성장할 것으로 예측되고 있습니다.

목차

제1장 주요 요약

  • 시장 스냅숏
  • 세계·부문별 시장 추정·예측, 2019-2029년
    • 성감염증(STD) 검사 시장 : 지역별, 2019-2029년
    • 성감염증(STD) 검사 시장 : 질환 유형별, 2019-2029년
    • 성감염증(STD) 검사 시장 : 검사장소별, 2019-2029년
  • 주요 동향
  • 조사 방법
  • 조사 전제조건

제2장 세계의 성감염증(STD) 검사 시장 정의와 범위

  • 조사의 목적
  • 시장의 정의와 범위
    • 조사 대상 범위
    • 산업의 진화
  • 조사 대상년
  • 통화 환산율

제3장 세계의 성감염증(STD) 검사 시장 역학

  • 성감염증(STD) 검사 시장 영향 분석(2019-2029년)
    • 시장 촉진요인
      • 세계에서 STD의 유병률 증가
      • STD에 대한 유리한 진료 보수 정책
      • 대형 시장 기업의 전략적 구상
    • 시장이 해결해야 할 과제
      • 검사기기에 관련된 고비용
      • 성병에 관련된 사회적 낙인
    • 시장 기회
      • 개발도상 지역에서 헬스케어·인프라의 확대
      • STD 유행에 대한 환자 의식의 향상

제4장 세계의 성감염증(STD) 검사 시장 산업 분석

  • Porter's 5 Force 모델
    • 공급 기업의 교섭력
    • 구매자의 교섭력
    • 신규 진출업체의 위협
    • 대체품의 위협
    • 경쟁 기업간 경쟁 관계
  • Porter's 5 Force 모델에 대한 미래적 어프로치(2019-2029년)
  • PEST 분석
    • 정치적
    • 경제적
    • 사회적
    • 기술적
  • 투자 채택 모델
  • 애널리스트의 결론·제안
  • TOP 투자 기회
  • 주요 성공 전략

제5장 리스크 평가 : COVID-19의 영향

  • COVID-19가 업계에 미치는 전체적인 영향 평가
  • COVID-19 이전과 COVID-19 이후 시장 시나리오

제6장 세계의 성감염증(STD) 검사 시장 : 질환 유형별

  • 시장 스냅숏
  • 세계의 성감염증(STD) 검사 시장 : 질환 유형별, 퍼포먼스 - 잠재력 분석
  • 세계의 성감염증(STD) 검사 시장 : 질환 유형별 추정·예측 2019-2029년
  • 성감염증(STD) 검사 시장 : 하위 부문 분석
    • 클라미디아
    • 임질
    • 단순 헤르페스 바이러스
    • 매독
    • 인유두종바이러스(HPV)
    • 기타 질병(인간면역결핍바이러스(HIV), 갑상선종, 트리코모나스, B형 간염 등)

제7장 세계의 성감염증(STD) 검사 시장 : 검사장소별

  • 시장 스냅숏
  • 세계의 성감염증(STD) 검사 시장 : 검사 부위별, 실적 - 잠재력 분석
  • 세계의 성감염증(STD) 검사 시장 : 검사장소별 추정·예측 : 2019-2029년
  • 성감염증(STD) 검사 시장 : 하위 부문 분석
    • 시험기관 테스트
    • POC(Point of Care) 검사

제8장 세계의 성감염증(STD) 검사 시장 : 지역별 분석

  • 성감염증(STD) 검사 시장, 지역별 시장 스냅숏
  • 북미
    • 미국
      • 질환 유형별 추정·예측, 2019-2029년
      • 검사장소별 추정·예측, 2019-2029년
    • 캐나다
  • 유럽의 성감염증(STD) 검사 시장 스냅숏
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 기타 유럽 지역
  • 아시아태평양의 성감염증(STD) 검사 시장 스냅숏
    • 중국
    • 인도
    • 일본
    • 호주
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카의 성감염증(STD) 검사 시장 스냅숏
    • 브라질
    • 멕시코
  • 세계의 기타 지역

제9장 경쟁 정보

  • 주요 시장 전략
  • 기업 개요
    • Abbott Laboratories
      • 주요 정보
      • 개요
      • 재무(데이터 입수가 가능한 경우)
      • 제품 개요
      • 최근 개발 상황
    • Becton Dickinson Company
    • Biomerieux, Inc.
    • Bio-Rad Laboratories Inc.
    • Danaher Corporation
    • Diasorin Molecular LLC
    • Hologic Inc.
    • Orasure Technologies, Inc.
    • Roche Holdings Ag
    • Thermo Fisher Scientific(Affymetrix)

제10장 조사 프로세스

  • 조사 프로세스
    • 데이터 마이닝
    • 분석
    • 시장 추정
    • 밸리데이션
    • 출판
  • 조사 속성
  • 조사 전제조건
KSA 22.11.24

Global Sexually Transmitted Diseases (STD) Testing Market is valued approximately USD 96.06 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5.1% over the forecast period 2022-2029. Sexually Transmitted Diseases (STD) refer to infection transmitted from an infected person to an uninfected person through sextual contact. STDs are caused by bacteria, and viruses. Chlamydia, Gonorrhea, Herpes Simplex Virus, Syphilis, Human Papillomavirus (HPV), and Human Immunodeficiency Virus among others are different kind of STDs. The increasing prevalence of STDs worldwide and favorable reimbursement policies for STDs as well as strategic initiatives from leading market players are key factors accelerating the market growth.

According to the World Health Organization (WHO) estimates - in 2020, globally around 374 million new cases of STIs were reported. In addition, the most prevalent type of infection was chlamydia with 129 million cases, followed by gonorrhoea with 82 million cases, syphilis with 7.1 million cases and trichomoniasis with 156 million cases. Also, growing healthcare infrastructure in the developing regions and rising patient awareness towards STD prevalence would create lucrative growth prospectus for the market over the forecast period. However, the high cost associated with testing equipment and social stigma associated with STDs impede the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Sexually Transmitted Diseases (STD) Testing Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region in terms of market share due to factors such as presence of leading market players as well as availability of robust healthcare infrastructure in the region. Whereas Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising prevalence of STDs as well as increasing number of favorable initiatives from government authorities in terms of awareness campaigns and reimbursement policies in the region.

Major market players included in this report are:

Abbott Laboratories

Becton Dickinson Company

Biomerieux, Inc.

Bio-Rad Laboratories Inc.

Danaher Corporation

Diasorin Molecular Llc

Hologic Inc.

Orasure Technologies, Inc.

Roche Holdings Ag

Thermo Fisher Scientific (Affymetrix)

Recent Developments in the Market:

  • In June 2019, Quest Diagnostics, launched three laboratory testing packages for sexually transmitted diseases (STDs). The package would cover chlamydia, gonorrhea, and syphilis, would be available for online purchase by individuals across the United States.
  • In April 2022, USA based Chiricahua Community Health Centers, Inc. (CCHCI) entered in a collaboration with The Body Agency Collective (TBAC) and Visby Medical, Inc., to enhance the diagnosis and treatment of sexually transmitted infection (STI). Under this project the community health center would utilize PCR diagnostic device, the Sexual Health Click Test to test STIs in women within 30 minutes.

Global Sexually Transmitted Diseases (STD) Testing Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered Disease Type, Location of Testing, Region

Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Disease Type

Chlamydia

Gonorrhea

Herpes Simplex Virus

Syphilis

Human Papillomavirus (HPV)

Human Immunodeficiency Virus (HIV)

Other Diseases

By Location of Testing

Laboratory Testing

Point-of-care (POC) Testing)

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Sexually Transmitted Diseases (STD) Testing Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Sexually Transmitted Diseases (STD) Testing Market, by Disease Type, 2019-2029 (USD Billion)
    • 1.2.3. Sexually Transmitted Diseases (STD) Testing Market, by Location of Testing, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Sexually Transmitted Diseases (STD) Testing Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Sexually Transmitted Diseases (STD) Testing Market Dynamics

  • 3.1. Sexually Transmitted Diseases (STD) Testing Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of STDs worldwide.
      • 3.1.1.2. Favourable reimbursement policies for STDs
      • 3.1.1.3. Strategic initiatives from leading market players.
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost associated with testing equipment.
      • 3.1.2.2. Social stigma associated with STDs
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing healthcare infrastructure in the developing regions.
      • 3.1.3.2. Rising patient awareness towards STD prevalence.

Chapter 4. Global Sexually Transmitted Diseases (STD) Testing Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Sexually Transmitted Diseases (STD) Testing Market, by Disease Type

  • 6.1. Market Snapshot
  • 6.2. Global Sexually Transmitted Diseases (STD) Testing Market by Disease Type, Performance - Potential Analysis
  • 6.3. Global Sexually Transmitted Diseases (STD) Testing Market Estimates & Forecasts by Disease Type 2019-2029 (USD Billion)
  • 6.4. Sexually Transmitted Diseases (STD) Testing Market, Sub Segment Analysis
    • 6.4.1. Chlamydia
    • 6.4.2. Gonorrhea
    • 6.4.3. Herpes simplex virus
    • 6.4.4. Syphilis
    • 6.4.5. Human papillomavirus (HPV)
    • 6.4.6. Other diseases (human immunodeficiency virus (HIV), chancroid, trichomoniasis, and hepatitis B)

Chapter 7. Global Sexually Transmitted Diseases (STD) Testing Market, by Location of Testing

  • 7.1. Market Snapshot
  • 7.2. Global Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, Performance - Potential Analysis
  • 7.3. Global Sexually Transmitted Diseases (STD) Testing Market Estimates & Forecasts by Location of Testing 2019-2029 (USD Billion)
  • 7.4. Sexually Transmitted Diseases (STD) Testing Market, Sub Segment Analysis
    • 7.4.1. Laboratory testing
    • 7.4.2. Point of care (POC) testing

Chapter 8. Global Sexually Transmitted Diseases (STD) Testing Market, Regional Analysis

  • 8.1. Sexually Transmitted Diseases (STD) Testing Market, Regional Market Snapshot
  • 8.2. North America Sexually Transmitted Diseases (STD) Testing Market
    • 8.2.1. U.S. Sexually Transmitted Diseases (STD) Testing Market
      • 8.2.1.1. Disease Type breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Location of Testing breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Sexually Transmitted Diseases (STD) Testing Market
  • 8.3. Europe Sexually Transmitted Diseases (STD) Testing Market Snapshot
    • 8.3.1. U.K. Sexually Transmitted Diseases (STD) Testing Market
    • 8.3.2. Germany Sexually Transmitted Diseases (STD) Testing Market
    • 8.3.3. France Sexually Transmitted Diseases (STD) Testing Market
    • 8.3.4. Spain Sexually Transmitted Diseases (STD) Testing Market
    • 8.3.5. Italy Sexually Transmitted Diseases (STD) Testing Market
    • 8.3.6. Rest of Europe Sexually Transmitted Diseases (STD) Testing Market
  • 8.4. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Snapshot
    • 8.4.1. China Sexually Transmitted Diseases (STD) Testing Market
    • 8.4.2. India Sexually Transmitted Diseases (STD) Testing Market
    • 8.4.3. Japan Sexually Transmitted Diseases (STD) Testing Market
    • 8.4.4. Australia Sexually Transmitted Diseases (STD) Testing Market
    • 8.4.5. South Korea Sexually Transmitted Diseases (STD) Testing Market
    • 8.4.6. Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market
  • 8.5. Latin America Sexually Transmitted Diseases (STD) Testing Market Snapshot
    • 8.5.1. Brazil Sexually Transmitted Diseases (STD) Testing Market
    • 8.5.2. Mexico Sexually Transmitted Diseases (STD) Testing Market
  • 8.6. Rest of The World Sexually Transmitted Diseases (STD) Testing Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Abbott Laboratories
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Becton Dickinson Company
    • 9.2.3. Biomerieux, Inc.
    • 9.2.4. Bio-Rad Laboratories Inc.
    • 9.2.5. Danaher Corporation
    • 9.2.6. Diasorin Molecular LLC
    • 9.2.7. Hologic Inc.
    • 9.2.8. Orasure Technologies, Inc.
    • 9.2.9. Roche Holdings Ag
    • 9.2.10. Thermo Fisher Scientific (Affymetrix)

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제